The Surgical Management of the Mesentery in Crohn's Disease
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Increasing evidence suggests that Crohn's disease is a primary mesenteropathy and that resection of the mesentery, or its exclusion from an anastomosis, may alter disease progression. If borne out in clinical trials, this observation would be welcome, as current pharmacotherapeutic approaches to Crohn's disease appear to have limited effect on disease progression. This article explores arguments for and against the alteration of mesenteric inputs by surgical means, in Crohn's disease.
References
1.
Coffey J, OLeary D, Kiernan M, Faul P
. The mesentery in Crohn's disease: friend or foe?. Curr Opin Gastroenterol. 2016; 32(4):267-73.
DOI: 10.1097/MOG.0000000000000280.
View
2.
de Groof E, van der Meer J, Tanis P, de Bruyn J, van Ruler O, DHaens G
. Persistent Mesorectal Inflammatory Activity is Associated With Complications After Proctectomy in Crohn's Disease. J Crohns Colitis. 2018; 13(3):285-293.
DOI: 10.1093/ecco-jcc/jjy131.
View
3.
Sahebally S, Burke J, Chang K, Kiernan M, OConnell P, Coffey J
. Circulating fibrocytes and Crohn's disease. Br J Surg. 2013; 100(12):1549-56.
DOI: 10.1002/bjs.9302.
View
4.
Becker M, van der Does de Willebois E, Bemelman W, Wildenberg M, Buskens C
. Role of the Mesentery in Crohn's Terminal Ileitis. Clin Colon Rectal Surg. 2022; 35(4):316-320.
PMC: 9376045.
DOI: 10.1055/s-0042-1743589.
View
5.
Buskens C, de Groof E, Bemelman W, Wildenberg M
. The role of the mesentery in Crohn's disease. Lancet Gastroenterol Hepatol. 2017; 2(4):245-246.
DOI: 10.1016/S2468-1253(17)30049-3.
View